期刊文献+

Reperfusion injury after critical intestinal ischemia and its correction with perfluorochemical emulsion "perftoran"

Reperfusion injury after critical intestinal ischemia and its correction with perfluorochemical emulsion "perftoran"
下载PDF
导出
摘要 AIM: To investigate the anti-ischemic properties of perfluorochemical emulsion "perftoran" in mesenteric region. METHODS: Experiments were conducted on 146 nonlinear white male rats weighing 200-350 g. Partial critical intestinal ischemia was induced by thorough atraumatic strangulation of 5-6 cm jejunal loop with its mesentery for 90 rain. Global critical intestinal ischemia was made by atraumatic occlusion of the cranial mesenteric artery (CMA) for 90 rain also. Perftoran (PF, 0.8-1.0 mL per 100 g) in experimental groups or 0.9% sodium chloride in control groups was injected at 75 rain of ischemic period. Mean systemic arterial blood pressure (BPM) registration, intravital microscopy and morphological examination of ischemic intestine and its mesentery were performed in both groups. RESULTS: During 90 min of reperfusion, BPM progressively decreased to 27.3±7.4% after PF administration vs 38.6±8.0% in the control group of rats with partial intestinal ischemia (NS) and to 50.3±6.9% vs 53.1±5.8% in rats after global ischemia (NS). During the reperfusion period, full restoration of microcirculation was never registered; parts with restored blood flow had leukocyte and erythrocyte stasis and intra-vascular clotting, a typical "non-reflow"phenomenon. The reduction of mesenteric 50-400 μm feeding artery diameter was significantly less in the PF group than in the control group (24±5.5% vs 45.2±3.6%, P〈0.05) 5 min after partial intestinal ischemia. This decrease progressed but differences between groups minimized at the 90th min of reperfusion (41.5±4.2% and 50.3±2.8%, respectively). In reperfusion of rat's intestine, a significant mucosal alteration was registered. Villous height decreased 2.5-3 times and the quantity of crypts decreased more than twice. In the group of rats administered PF, intestinal mucosal layer was protected from irreversible post-ischemic derangement during reperfusion. Saved cryptal epithelial cells were the source of regeneration of the epithelium, which began to cover renewing intestinal villi after 24 h of blood flow restoration. View of morphological alterations was more heterogeneous in CMA groups. CONCLUSION: Systemic administration of perftoran promotes earlier and more complete structural regeneration during reperfusion in rats after partial and global critical intestinal ischemia. AIM: To investigate the anti-ischemic properties of perfluorochemical emulsion 'perftoran' in mesenteric region.METHODS: Experiments were conducted on 146nonlinear white male rats weighing 200-350 g. Partial critical intestinal ischemia was induced by thorough atraumatic strangulation of 5-6 cm jejunal loop with its mesentery for 90 min. Global critical intestinal ischemia was made by atraumatic occlusion of the cranial mesenteric artery (CMA) for 90 min also. Perftoran (PF,0.8-1.0 mL per 100 g) in experimental groups or 0.9%sodium chloride in control groups was injected at 75min of ischemic period. Mean systemic arterial blood pressure (BPM) registration, intravital microscopy and morphological examination of ischemic intestine and its mesentery were performed in both groups.RESULTS: During 90 min of reperfusion, BPM progressively decreased to 27.3±7.4% after PF administration vs 38.6±8.0% in the control group of rats with partial intestinal ischemia (NS) and to 50.3±6.9% vs 53.1±5.8% in rats after global ischemia (NS). During the reperfusion period, full restoration of microcirculation was never registered; parts with restored blood flow had leukocyte and erythrocyte stasis and intra-vascular clotting, a typical 'non-reflow'phenomenon. The reduction of mesenteric 50-400 μmfeeding artery diameter was significantly less in the PF group than in the control group (24±5.5% vs 45.2±3.6%,P<0.05) 5 min after partial intestinal ischemia. This decrease progressed but differences between groups minimized at the 90th min of reperfusion (41.5±4.2%and 50.3±2.8%, respectively). In reperfusion of rat's intestine, a significant mucosal alteration was registered.Villous height decreased 2.5-3 times and the quantity of crypts decreased more than twice. In the group of rats administered PF, intestinal mucosal layer was protected from irreversible post-ischemic derangement during reperfusion. Saved cryptal epithelial cells were the source of regeneration of the epithelium, which began to cover renewing intestinal villi after 24 h of blood flow restoration. View of morphological alterations was more heterogeneous in CMA groups.CONCLUSION: Systemic administration of perftoran promotes earlier and more complete structural regeneration during reperfusion in rats after partial and global critical intestinal ischemia.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第45期7084-7090,共7页 世界胃肠病学杂志(英文版)
关键词 Rats Ischemia-reperfusion injury GUT INTESTINE Perfluorocarbon emulsions 灌注损伤 肠缺血 全氟化合物 乳剂
  • 相关文献

参考文献25

  • 1[1]Parks DA,Grogaard B,Granger DN.Comparison of partial and complete arterial occlusion models for studying intestinal ischemia.Surgery 1982; 92:896-901
  • 2[2]Granger DN.Ischemia-reperfusion:mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease.Microcirculation 1999; 6:167-178
  • 3[3]Betzler M.Surgical technical guidelines in intestinal ischemia.Chirurg 1998; 69:1-7
  • 4[4]Bjorck M.Colonic ischemia after aortoiliac surgery.Regionar Krovoobr i Microcirc 2002; 1:10-16
  • 5[5]Grant D.Intestinal transplantation:1997 report of the international registry.Intestinal Transplant Registry.Transplantation 1999; 67:1061-1064
  • 6[6]Bauer R,Kerschbaumer F.The results of Chiari's medial displacement osteotomy.Arch Orthop Unfallchir 1975; 81:301-314
  • 7[7]O'Donnell KA,Caty MG,Zheng S,Rossman JE,Azizkhan RG.Oxygenated intraluminal perfluorocarbon protects intestinal muscosa from ischemia/reperfusion injury.J Pediatr Surg 1997;32:361-365
  • 8[8]Kligunenko EN,Kompaniets NG.Possibilities of Perftoran application in complex anti-paretic therapy after operations through laparotomy// Perfluorocarbons in Biology and Medicine:Proc.of Symp./Ed.by G.R.Ivanitsky,V.V.Moroz.Puschino,2001:133-136,Russian
  • 9[9]Maltseva LA,Mosentsev NF.Effects of Perftoran in patients with septic shock; block of cytokine chain as way of SIRS progression prophylaxis// Perfluorocarbons in Biology and Medicine:Proc.of Symp./Ed.by G.R.Ivanitsky,V.V.Moroz.Puschino,2001:210-217,Russian
  • 10[10]Ohara M,Unno N,Mitsuoka H,Kaneko H,Nakamura S.Peritoneal lavage with oxygenated perfluorochemical preserves intestinal mucosal barrier function after ischemia-reperfusion and ameliorates lung injury.Crit Care Med 2001; 29:782-788

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部